摘要
The Journal of DermatologyEarly View LETTER TO THE EDITOR A case of erosive pustular dermatosis of the scalp with ulcerative colitis successfully treated with upadacitinib Shuji Sugiura, Corresponding Author Shuji Sugiura [email protected] orcid.org/0009-0003-5891-1317 Department of Dermatology, Department of Gastroenterology of Shiga University of Medical Science Hospital, Otsu, Shiga, Japan Correspondence Shuji Sugiura, Department of Dermatology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan. Email: [email protected]Search for more papers by this authorBunpei Yamamoto, Bunpei Yamamoto Department of Dermatology, Department of Gastroenterology of Shiga University of Medical Science Hospital, Otsu, Shiga, JapanSearch for more papers by this authorNoriki Fujimoto, Noriki Fujimoto orcid.org/0000-0003-4051-0649 Department of Dermatology, Department of Gastroenterology of Shiga University of Medical Science Hospital, Otsu, Shiga, JapanSearch for more papers by this author Shuji Sugiura, Corresponding Author Shuji Sugiura [email protected] orcid.org/0009-0003-5891-1317 Department of Dermatology, Department of Gastroenterology of Shiga University of Medical Science Hospital, Otsu, Shiga, Japan Correspondence Shuji Sugiura, Department of Dermatology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan. Email: [email protected]Search for more papers by this authorBunpei Yamamoto, Bunpei Yamamoto Department of Dermatology, Department of Gastroenterology of Shiga University of Medical Science Hospital, Otsu, Shiga, JapanSearch for more papers by this authorNoriki Fujimoto, Noriki Fujimoto orcid.org/0000-0003-4051-0649 Department of Dermatology, Department of Gastroenterology of Shiga University of Medical Science Hospital, Otsu, Shiga, JapanSearch for more papers by this author First published: 28 May 2024 https://doi.org/10.1111/1346-8138.17282Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Starace M, Alessandrini A, Baraldi C, Piraccini BM. Erosive pustular dermatosis of the scalp: challenges and solutions. Clin Cosmet Investig Dermatol. 2019; 12: 691–698. 10.2147/CCID.S223317 PubMedWeb of Science®Google Scholar 2Jordan AA, Higgins PD. The role of upadacitinib in the treatment of ulcerative colitis. Immunotherapy. 2023; 15: 713–727. 10.2217/imt-2022-0299 CASPubMedWeb of Science®Google Scholar 3Parmentier JM, Voss J, Graff C, Schwartz A, Argiriadi M, Friedman M, et al. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatol. 2018; 2: 23. 10.1186/s41927-018-0031-x PubMedGoogle Scholar 4Wan H, Jia H, Xia T, Zhang D. Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: a network meta-analysis. Dermatol Ther. 2022; 35:e15636. 10.1111/dth.15636 CASPubMedWeb of Science®Google Scholar 5Duggan S, Keam SJ. Upadacitinib: first approval. Drugs. 2019; 79: 1819–1828. 10.1007/s40265-019-01211-z PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation